The American Journal of Managed Care1d
Disease Activity, Safety Remain Following Switch From Infliximab Biosimilar to Originator in IBD
Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...
Rupert Resources Completes Pre-Feasibility for Ikkari Confirming a High-Margin Project Net Present Value of USD1.7 Billion and IRR of 38%
Rupert Resources Ltd ("Rupert" or the "Company") has completed a Pre-feasibility study ("PFS" or "study") for its 100% owned ...
Workplace diversity and inclusion: Trends to watch out for
Workplace trends have evolved significantly over the years, from focusing on compliance to cultivating inclusive work cultures that value individuality. These advances become clearer with firms taking ...